Antibody COVID-19 Therapies Back in China Spotlight Amid Infection Surge

 
• By Dexter Jie Yan

Chinese developers forge ahead with research into antibody therapies for COVID-19 as coronavirus variants gain a toe-hold in the country.

China biotechs work on antibody COVID-19 therapies
Three China-based biotechs are still chasing antibody COVID-19 therapies • Source: Alamy

More from China

More from Focus On Asia